APA (7th ed.) Citation

Mizrahi M, Shabat Y, Ben Ya'acov A, Lalazar G, Adar T, Wong V, . . . Ilan Y. (2012). Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: Results of a phase I/II clinical trial in NASH. Dove Medical Press.

Chicago Style (17th ed.) Citation

Mizrahi M, Shabat Y, Ben Ya'acov A, Lalazar G, Adar T, Wong V, Muller B, Rawlin G, and Ilan Y. Alleviation of Insulin Resistance and Liver Damage by Oral Administration of Imm124-E Is Mediated by Increased Tregs and Associated with Increased Serum GLP-1 and Adiponectin: Results of a Phase I/II Clinical Trial in NASH. Dove Medical Press, 2012.

MLA (9th ed.) Citation

Mizrahi M, et al. Alleviation of Insulin Resistance and Liver Damage by Oral Administration of Imm124-E Is Mediated by Increased Tregs and Associated with Increased Serum GLP-1 and Adiponectin: Results of a Phase I/II Clinical Trial in NASH. Dove Medical Press, 2012.